PHARMARON MANUFACTURING SERVICES (UK) LTD
Get an alert when PHARMARON MANUFACTURING SERVICES (UK) LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-07-28 (in 2mo)
Last made up 2025-07-14
Watchouts
Cash
£2M
-34.6% vs 2023
Net assets
—
Equity attributable
Employees
138
0% vs 2023
Profit before tax
-£16M
-1.6% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
The directors concluded that the entity requires support from the ultimate parent Company to meet liquidity needs during the going concern period. The Directors have obtained a letter of support from Pharmaron Beijing Co Ltd, confirming willingness to provide financial support. Directors believe the Company has adequate resources to continue in operational existence for the next twelve months.
-
1 PSC ceased in last 24 months
Significant control changed hands — see the Ownership section.
Profit before tax
5-year trend · vs Health Care median
Accounts
5-year trend · latest reflected 2024-12-31
| Metric | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | |
| Profit before tax | — | — | — | -£16,065,312 | -£16,325,573 | |
| Net profit | — | — | — | — | — | |
| Cash | — | — | — | £2,763,713 | £1,808,106 | |
| Total assets less current liabilities | — | — | — | — | — | |
| Net assets | — | — | — | — | — | |
| Equity | £11,918,921 | £48,215 | £48,215 | £469,741 | -£21,714,470 | |
| Average employees | — | — | — | 138 | 138 | |
| Wages | — | — | — | £6,683,036 | £6,929,919 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Azets Audit Services
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“The directors concluded that the entity requires support from the ultimate parent Company to meet liquidity needs during the going concern period. The Directors have obtained a letter of support from Pharmaron Beijing Co Ltd, confirming willingness to provide financial support. Directors believe the Company has adequate resources to continue in operational existence for the next twelve months.”
Significant events
- “The strategic development of the site has continued in 2024 with the approval of a further ~£3.75m of capital investment in modular configuration and upgrade of technical capabilities.”
- “The Company had negative net assets of £21.7m at the period-end (2023: £25.8m).”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 37 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LEWINTON, Stephen Christopher, Mr. | Secretary | 2022-01-07 | — | — |
| LEWINTON, Stephen Christopher, Mr. | Director | 2022-01-07 | Apr 1966 | British |
| LOU, Boliang, Dr | Director | 2022-01-07 | Sep 1963 | American |
Show 37 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HAYES, Paul Andrew | Secretary | 2018-02-28 | 2018-09-07 |
| ILETT, John Edward | Secretary | 2015-11-02 | 2018-02-28 |
| JACKSON, Andrew Leonard | Secretary | 2018-09-07 | 2020-04-30 |
| JONES, Nick | Secretary | 2009-11-27 | 2014-11-12 |
| SIMS, Adam Duncan | Secretary | 2004-08-16 | 2009-11-30 |
| WARD, Iain Stuart | Secretary | 2014-11-12 | 2015-11-02 |
| EVERSECRETARY LIMITED | Corporate Nominee Secretary | 2004-07-23 | 2004-08-16 |
| AVERY, Paul John | Director | 2014-11-12 | 2015-11-02 |
| BOERMAN, Manja Hermina Elisabeth Maria, Dr | Director | 2017-05-22 | 2019-11-30 |
| BROWN, Tom | Director | 2004-08-31 | 2009-01-20 |
| COTTON, Richard John | Director | 2014-11-12 | 2016-12-13 |
| DODS, Samuel Charles | Director | 2004-08-16 | 2005-05-11 |
| ELDERED, Thomas Bengt | Director | 2020-02-04 | 2021-04-09 |
| GLENN, Jonathan Martin | Director | 2014-11-12 | 2020-02-04 |
| GOWLAND, Christopher David | Director | 2014-11-12 | 2015-10-30 |
| GOWLAND, Christopher David | Director | 2010-01-01 | 2010-12-31 |
| GOWLAND, Christopher | Director | 2004-08-16 | 2006-10-09 |
| HARDY, Robert, Dr | Director | 2004-08-16 | 2014-11-12 |
| HARRISON, Steven Richard | Director | 2009-08-28 | 2011-10-11 |
| HAYES, Paul Andrew | Director | 2017-05-01 | 2020-02-04 |
| HUNNYBALL, Ian Michael, Professor | Director | 2007-03-01 | 2009-03-11 |
| JONES, Nicholas Vaughan | Director | 2009-11-27 | 2014-11-12 |
| LEACH, Andy | Director | 2008-11-26 | 2009-06-18 |
| MACKENZIE, David Arthur | Director | 2011-10-11 | 2011-11-29 |
| MCCONNELL, John Martin | Director | 2011-10-11 | 2014-11-12 |
| MCCONNELL, John | Director | 2010-01-01 | 2010-12-31 |
| MUIR, Ian Stuart | Director | 2014-11-12 | 2017-05-18 |
| PALMER, Jarrett Vincent | Director | 2014-11-12 | 2015-05-28 |
| PARKER, John Francis | Director | 2009-03-01 | 2011-10-11 |
| PLUTA, Bernard | Director | 2021-04-09 | 2022-01-07 |
| QUICK, Mark Royston | Director | 2020-06-15 | 2022-01-07 |
| RANKIN, Alan | Director | 2004-08-16 | 2006-10-09 |
| SIMS, Adam Duncan | Director | 2004-08-16 | 2010-12-31 |
| WARD, Iain Stuart | Director | 2014-11-12 | 2015-11-02 |
| WILKINSON, Craig | Director | 2004-08-31 | 2008-11-26 |
| YURKWICH, Adrian | Director | 2011-10-11 | 2011-11-29 |
| EVERDIRECTOR LIMITED | Corporate Nominee Director | 2004-07-23 | 2004-08-16 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Xiaoqiang Lou | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2025-03-05 | Active |
| Bei Zheng | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2025-03-05 | Active |
| Boliang Lou | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2025-03-05 | Active |
| Pharmaron Uk Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2022-01-07 | Ceased 2025-03-05 |
| Consort Medical Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-10-20 | Ceased 2022-01-07 |
| Consort Medical Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Ceased 2020-10-20 |
Filing timeline
Last 20 of 274 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-28 | SH01 | capital | Capital allotment shares | |
| 2025-07-29 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-07-28 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2025-07-28 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-07-28 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-07-28 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-07-28 | SH01 | capital | Capital allotment shares | |
| 2025-06-18 | AA | accounts | Accounts with accounts type full | |
| 2024-11-08 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-08-12 | SH01 | capital | Capital allotment shares | |
| 2024-07-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-06-03 | AA | accounts | Accounts with accounts type full | |
| 2023-09-20 | AA | accounts | Accounts with accounts type full | |
| 2023-07-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-17 | AD04 | address | Move registers to registered office company with new address | |
| 2022-12-30 | AA | accounts | Accounts with accounts type full | |
| 2022-10-21 | CH03 | officers | Change person secretary company with change date | |
| 2022-10-21 | CH01 | officers | Change person director company with change date | |
| 2022-10-20 | CH01 | officers | Change person director company with change date | |
| 2022-08-01 | CS01 | confirmation-statement | Confirmation statement with updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 8
- Capital events
- 3
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
-34.6%
£2,763,713 £1,808,106
-
Net assets
—
Not reported
-
Employees
0%
138 138
-
Profit before tax
-1.6%
-£16,065,312 -£16,325,573
-
Wages
+3.7%
£6,683,036 £6,929,919
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers